Answers are grounded in this paper and cite their sources.
The monograph constructs operating tolerance for the entropic certainty equivalent from financial-plan capacity through specified valuation and governance maps, without attributing psychological preferences to the firm. Viability under stress defines directional capacity; monetisation expresses it in money; a specified map assigns maximum available tolerance; and governance defines the operating permissions within which tolerance is selected or optimised. The construction distinguishes financial flexibility, risk capacity, risk appetite and limits, and establishes conditions under which scalar capacity represents locally derived tolerance. Under the maintained decision model, observed capacity and choices identify at most the composite capacity-to-operating-tolerance map on observed support; separating its components requires independent restrictions. The central contribution is the production and economic cost of risk tolerance. Commitment fees, carrying costs and the opportunity cost of resources devoted to risk bearing define a minimum-cost tolerance frontier from explicit financial technologies. Instrument caps, inherited headroom, fixed acquisition charges and substitution shape this frontier; resource stocks, expenditure and governance penalties remain distinct. In the fixed-loss reduced problem, a positive smooth interior optimum equates marginal production cost with the relative entropy of the exponentially tilted loss law with respect to the reference law, under stated regularity conditions. This entropy measures the marginal reduction in entropic loss valuation. Direct dependence of losses, transfer costs or constraints on tolerance introduces additional terms; boundary and nonsmooth cases require corresponding conditions. The instrument-level problem reduces exactly to the scalar frontier when costs and authorised operating tolerances exhaust the instruments’ effects; otherwise, direct effects on losses, operating value and admissible decisions remain in the integrated formulation. Tolerance costs therefore influence risk retention, transfer and mitigation. The analysis also treats measurement and calibration, dynamic decisions, model uncertainty, pooling and diversification, and risk sharing among participants with costly tolerances. Analytical examples and a synthetic industrial illustration, supported by reproducible computational materials, examine joint optimisation and sensitivity. These exercises assess internal consistency; empirical identification and validation remain research priorities.
No takes yet. Share an insight, caveat, or question.
Renato Ghisellini (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: